The next board meeting for Arrowhead Pharma Inc is on 19 Mar 2026 for the purpose of Arrowhead Pharmaceuticals Inc Annual General Meeting for 2025See details
Arrowhead Pharma Inc has a share price target of US$ 81, revenue growth forecast of -46.0%, and profit growth estimate of -30202.5% for FY26, based on top 12 analyst calls.